On Tuesday, April 25 (10:00 am-4:00 pm), the FDA will host a virtual public meeting on Patient-Focused Drug Development for Long COVID to hear from those experiencing Long COVID.
The event is a chance to share symptoms and experiences with the disease and interactions with the health care system. People will also have the opportunity to talk about clinical trials and their conditions for participation.
Register for the online event.
Comments may be submitted online and via snail mail (Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852).
The meeting will be conducted with live translation in both English and Spanish.